234 related articles for article (PubMed ID: 35073459)
1. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
[TBL] [Abstract][Full Text] [Related]
3. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
[TBL] [Abstract][Full Text] [Related]
5. RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer.
Zhu L; Zhu Y; Li F; Meng Y; Wang H; Xu W; Luo J; Wang X; Feng L; Jin H
Clin Transl Med; 2023 Jul; 13(7):e1337. PubMed ID: 37477089
[TBL] [Abstract][Full Text] [Related]
6. LNC942 promoting METTL14-mediated m
Sun T; Wu Z; Wang X; Wang Y; Hu X; Qin W; Lu S; Xu D; Wu Y; Chen Q; Ding X; Guo H; Li Y; Wang Y; Fu B; Yao W; Wei M; Wu H
Oncogene; 2020 Jul; 39(31):5358-5372. PubMed ID: 32576970
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer.
Yang H; Hu Y; Weng M; Liu X; Wan P; Hu Y; Ma M; Zhang Y; Xia H; Lv K
J Adv Res; 2022 Mar; 37():91-106. PubMed ID: 35499052
[TBL] [Abstract][Full Text] [Related]
8. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
9. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
Zhang YF; Li CS; Zhou Y; Lu XH
Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
11. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer.
Dong Y; Li X; Lin Z; Zou W; Liu Y; Qian H; Jia J
J Exp Clin Cancer Res; 2019 Dec; 38(1):502. PubMed ID: 31870402
[TBL] [Abstract][Full Text] [Related]
12. Construction of a competing endogenous RNA network and identification of potential regulatory axes in gastric cancer chemoresistance.
Yang XZ; Ma L; Fang SX; Song Y; Zhu SY; Jin C; Liu W; Lu Q; Zeng LS; Cui SZ
Pathol Res Pract; 2022 Jun; 234():153904. PubMed ID: 35487029
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
[TBL] [Abstract][Full Text] [Related]
14. HCP5 contributes to cisplatin resistance in gastric cancer through miR-128/HMGA2 axis.
Liang L; Kang H; Jia J
Cell Cycle; 2021 Jun; 20(11):1080-1090. PubMed ID: 33993846
[TBL] [Abstract][Full Text] [Related]
15. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
[TBL] [Abstract][Full Text] [Related]
16. LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA.
Xu TP; Yu T; Xie MY; Fang Y; Xu TT; Pan YT; Ma P; Shu YQ
Gastric Cancer; 2023 Mar; 26(2):169-186. PubMed ID: 36284068
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
Zhu W; Tan L; Ma T; Yin Z; Gao J
Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
[TBL] [Abstract][Full Text] [Related]
18. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
[TBL] [Abstract][Full Text] [Related]
19. m
Yang D; Chang S; Li F; Ma M; Yang J; Lv X; Huangfu L; Jia C
IUBMB Life; 2021 Nov; 73(11):1325-1333. PubMed ID: 34409730
[TBL] [Abstract][Full Text] [Related]
20. An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction.
Yang DL; Dong LF; Qiu YB; Luo GY
Neoplasma; 2021 Sep; 68(5):1052-1062. PubMed ID: 34196212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
